tiprankstipranks
Trending News
More News >
Climb Bio (CLYM)
NASDAQ:CLYM
US Market

Climb Bio (CLYM) Income Statement

Compare
645 Followers

Climb Bio Income Statement

Last quarter (Q3 2025), Climb Bio's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Climb Bio's net income was $-12.89M. See Climb Bio’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 82.02M$ 40.27M$ 45.13M$ 35.67M$ 20.93M
Depreciation and Amortization
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
EBITDA
$ -30.36M$ -40.27M$ -45.13M$ -35.67M$ -11.77M
Operating Income
$ -82.02M$ -40.27M$ -45.13M$ -35.67M$ -20.93M
Other Income/Expenses
$ 8.12M$ 5.16M$ -109.00K$ -11.81M$ 257.00K
Pretax Income
$ -73.90M$ -35.12M$ -45.24M$ -47.48M$ -20.67M
Net Income
$ -73.90M$ -35.12M$ -45.24M$ -47.48M$ -20.67M
Per Share Metrics
Basic EPS
$ -1.14$ -1.30$ -1.72$ -4.24$ -1.97
Diluted EPS
$ -1.14$ -1.30$ -1.72$ -4.24$ -1.97
Weighted Average Shares Outstanding
48.16M 26.99M 26.31M 12.26M 11.66M
Weighted Average Shares Outstanding (Diluted)
48.16M 26.99M 26.31M 12.26M 11.66M
Currency in USD

Climb Bio Earnings and Revenue History